A limitation of exome and genome sequencing is that they can

A limitation of exome and genome sequencing is that_____ they cannot provide information about mitochondrial DNA they do not provide information about epigenetic they are blind to uniparental disomy they cannot detect gene-gene interactions all of the above What is the purpose of a pharmacogenomic test? Detection of variants of genes or gene expression patterns affecting drug metabolism Design of new pharmaceutical products Recommendation of vitamins and dietary supplements based on an individual os genotype Diagnosis of inherited disease Early identification of cancer which of the following is an example of a transgenic organism that is used for bioremediation? A bacteria infused with a human insulin gene A cow infused with a human milk protein gene A plant infused with a bacterial gene for a protein toxic to insects A plant infused with a bacterial gene for a protein to break down the environmental toxin mercury A fish infused with a gene from another fish s

Solution

Question 13 all the above

Explanation: exam Sequencing is limited in detecting the following types of mutations

1 large rearrangements

2 copy number variation mutations

3 mitochondrial genome mutations

4. Epigenetic factors

5 mosaic mutation

6 uniparental disomy

7 mutations in repetetive or highGC rich regions.

8. Mutations in genes with corresponding pseudoo genes.

Q14: a

The applications of pharmacogenomics the improve drug safety and reduced India tailor treatments to meet patients unique genetic predisposition identifying optimal dosing the improved drug Discovery targeted to human disease and they improve proof of principal for efficacy trails.

Q15: d

Bioremediation is a waste management technique that involves the use of organisms to remove are neutralized pollutants from a contaminated site.

DNA Sequencing is the process of determining the precise order of nucleotides within a DNA molecule.